clinical-trial – Page 7

Success! ASO drug reduces levels of mutant protein in Huntington's disease patients

Amazing news from Ionis and Roche! HTTRx drug successfully lowers harmful huntingtin protein in spinal fluid

December 11, 2017

Can we test drugs to delay or prevent the onset of Huntington's disease? New research suggests it's possible

October 27, 2017

WAVE Life Sciences launches PRECISION clinical trial to suppress the mutant Huntington's disease protein

August 25, 2017

Ionis says its trial of HTTRx, intended to lower huntingtin protein, is fully recruited and plans to extend it

June 22, 2017

A potential HD biomarker has been uncovered in a recent clinical study

June 7, 2017

Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease

April 5, 2017

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

December 16, 2016

HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD

September 30, 2016

HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore

June 13, 2016

HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD

April 18, 2016